Look Back Icon

NextGen Omics & Spatial Biology US 2025

For Every Patient.

Together, we can accelerate life changing, targeted, treatments.

NextGen Omics & Spatial Biology connects R&D specialists in pharma, biotech, academia and healthcare with pharmaceutical & biotech representatives to discuss the latest innovations across the fields of multi-omics.

There are three dedicated programmes running across two full days, which together will explore multi-omics from technological development to therapeutic applications and analysis, making this a must-attend event for anyone working in clinical diagnostics, single cell & spatial biology. 

NGO US Top Section Imagepng

Thank You For Attending

 Featured Panel Discussion (12.25, Conference Room 1)
  • Fostering Collaboration and Partnerships & Investment Trends Of AI In Multi-Omics For Drug Discovery & Development

    Moderator: VIRGINIA SAVOVA, Senior Director, AstraZeneca

Panel Discussion (14.40, Conference Room 3)

  • Novel Application Areas In Therapeutics
    For Single Cell Technologies

    Moderator: LEONARD LIPOVICH, Professor, Wayne State
    University School of Medicine

Case Study (15.30, Conference Room 4)

  • Exploring The 3D Tumor-Immune Ecosystem By Multiplexed
    Multi-Omics In Ovarian Cancer

    SAMMY FERRI-BORGOGNO, Assistant Professor
    in the Department of Gynecologic Oncology
    and Reproductive Medicine,
    University of Texas MD Anderson Cancer
    Center

 

 

NGO US Top Section Imagepng
NGO US Top Section Image 4

“For ourselves, our children, our grandchildren and the children of the world, we’re on the precipice of creating an opportunity to save lives within a blind spot that we have [previously] been ignoring in the practice of medicine”

Dr Robert Green

Professor of Medicine & Director of Genomes2People Research Program | Brigham and Women's Hospital

robert-green-headshot

Snapshots of NextGen Omics US

"The reason we are in this room is because it’s cutting edge"

Dr Jasmine Plummer

Director | St Jude Children's Research Hospital

jasmine-plummer

Lights, Camera, Action!

Explore our curated photo gallery of standout moments from NextGen Omics & Spatial Biology US 2025. See if you can spot yourself!

NextGen Biomed 2025

Advancing Therapeutic Innovation Through Multi-Omics Research  

NextGen Omics & Spatial Biology connects thought leaders, researchers, and experts with pharmaceutical & biotech representatives to discuss the latest innovations across the fields of multi-omics. 

There are three dedicated programmes running across two full days, which together will explore multi-omics from technological development to therapeutic applications and analysis, making this a must-attend event for anyone working in clinical diagnostics, single cell & spatial biology. 

Hear from past attendees of last year's Biologics 2024 conference

Explore the NextGen Omics & Spatial Biology US 2025 Programme

Antibody Society

NextGen Biomed 2025 is supported by our
Scientific Programme Partner The Antibody Society

What's been happening at NextGen Omics & Spatial Biology US 2025?

Have a peek into the dynamic panels, engaging roundtables, and hands-on workshops happening in Boston - right now!

spatial biology Track keynote address 
 Spatial Multi-Omics For Target-To-Disease Linkage In Inflammatory Diseases

MARINA BLECK, Principal Scientist, Boehringer Ingelheim

Marina discussed the use of multi omics for faster Faster Target-to- Disease Link (T2DL) with increased confidence and how they can leverage Spatial Biology to enhance the ability to derive insight from human disease tissues.  Finally the Importance of FFPE Tissue Quality for Spatial Biology was discussed with the use of QC scoring to determine which FFPE tissue gives the best spatial transcriptomics results.

spatial biology day one, track 6 
Spatial Biology As A Discovery Pathway

EMRE ARSLAN, Takeda

Emre Arslan from Takeda gave a talk about the use of Spatial Biology as a discovery pathway. First of all providing an update on the current landscape for spatial technologies then analysing how spatial technologies can be used in clinical trial design - such as the ability to identify previously unknown cell types, interactions and microenvironments and providing an ideal foundation for training better AI models. 

day 2 keynote
Single Cell into Spatial and Beyond: Landscape in 2025 and What’s Next?

JASMINE PLUMMER, Director, St Jude Children's Research Hosptial

Jasmine Plummer's day 2 keynote focused on Single cell into spatial and beyond.  "The reason we are in this room is because it’s cutting edge" which is why the single cell and spatial field growing exponentially.

Future directions for the technology include Low throughput, clinical trials, other organisms, more tissue types, epigenomics

Spatial multi-omics, track 4 Keynote
Rapid Single-Cell Spatial Proteomics by Spatial MIST

JUN WANG, Associate Professor, Multiplex Biotechnology Laboratory, Department of Biomedical Engineering, Stony Brook University

"Simpler but more powerful than flow and imaging cytometry"

MIST Technology provides100 times more information than flow cytometry and currently the highest multiplexity is up to 500 markers/ cell.

Single cell track keynote address
Panel Application Of Single Cell Omics In Clinical Monitoring

PRIYA CHOCKALINGAM, Vice President, Head of Clinical BioAnalytics & Translational Sciences, Beam Therapeutics

Priya's talk focused on Genome Editing Technologies for Gene & Cell Therapy and how cell & gene therapies require a specialized regulatory approach compared to other modalities. Appropriate assessments should therefore be put in place in both nonclinical and clinical stages to address safety concerns.

Various methods to assess off-target editing effects have evolved in the last decade. However, limitations remain in balancing accuracy vs sensitivity of these new techniques.

The direct assessment of off-target effects in vivo and in patients is particularly challenging.

Novel single-cell technologies enable quantitation/co-occurrence of on-/off-target editing through patient time-course of treatment

single cell  
Comparative Insights In Single Cell RNA-seq & Advances In Large-Scale Multimodal Profiling

ZORA MODRUSAN, Senior Director NGS, Genentech

Zora focused on both key insights and future directions of single cell RNA-Seq.  scRNA-seq technologies were evaluated and the differences in performance across various metrics such as sensitivity, throughput and cost were compared across different systems.

The Overloading And unpacKing (OAK) method provides a reliable solution for large-scale molecular profiling that incorporates multiple data modalities.

Moving forward they will continue to evaluate the latest scRNA-seq kits to understand differences and guide optimal performance. Zora would also like to enhance OAK's capabilities by integrating additional modalities and applying the platform to a wide range of biological systems.

Meet Our World Class Speakers

Aleksandra Markovets
Director,
AstraZeneca
Colles Price
Scientific Associate Director,
Takeda
Giorgio Gaglia
Senior Principal Scientist,
Sanofi
Jasmine Plummer
Director,
St Jude Children's Research Hospital
Maxime Dhainaut
Director of Functional Genomics,
Noetik
Pascaline Mary
Senior Director,
HiFiBiO Therapeutics
Priya Chockalingam
Vice President, Head of Clinical Bioanalytics & Translational Sciences,
Beam Therapeutics
Robert Green
Director, Genomes2People Research Program,
Brigham and Women's Hospital
Simona Cristea
Head of Data Science,
DFCI
Wenning Qin
Senior Vice President Innovation,
eGenesis
Yuchun Guo
Director of Computational Biology and Machine Learning,
Camp4 Therapeutics
Zora Modrusan
Sr. Director NGS,
Genentech
Alexandra Tsolias
Scientist II,
Voyager Therapeutics
Ali Ebrahimi
Associate Director ,
Takeda
Alice Wan
Senior Scientist,
Abbvie
Alina Ainbinder
Principal Scientist,
Takeda
Aridaman Pandit
Senior Principal Research Scientist,
Abbvie
Brian Cunningham
Professor,
University of Illinios
Deidre Dalmas Wilk
Director,
GSK
Dongdong Lin
Scientist,
EMD Serono
Elaine Lim
Assistant Professor,
UMass Chan Medical School
Elsa Molina
Director, Single-Cell & Spatial Omics,
Salk Institute
Emre Arslan
Associate Director,
Takeda
Eugean Jiwanmall
Senior Research Analyst,
Independence Blue Cross
Felix Francis
Senior Manager Data Management and Analytics,
Takeda
Gabor Balazsi
Professor,
Stony Brook University
Gang Wu
Associate Member,
St Jude Children's Research Hospital
Guolin Zhang
Principal Scientist,
Sensei Therapeutics
Ioannis Ragoussis
Professor,
McGill university
iulian Pruteanu-Malinici
Senior Director Bioinformatics,
Flagship Pioneering
Jan Schejbal
Senior Scientist,
AbbVie
Jia-Ren Lin
Director,
LSP, Harvard Medical School
Jun Wang
Associate Professor,
Stony Brook University
Kalotina Machini
Principal Investigator (Variant/Genomics) & Instructor in Pathology,
Harvard University
Kalpana Pillai
Technical Development Principal Scientist,
Genentech
Kieran Campbell
Assistant Professor & Research Group Lead,
University of Toronto & Lunenfeld-Tanenbaum Research Institute
Kimberly Smythe
Scientist,
Fred Hutchinson Cancer Center
Lana Garmire
Associate Professor,
University of Michigan
Leonora Balaj
Assistant Professor ,
Massachusetts General Hospital
Limeng Pu
Senior Computational Research Scientist,
St. Jude Children's Research Hospital
Lin Wu
Director, Genome Modification Facility,
Harvard University
Luca Pinello
Associate Professor of Pathology,
HARVARD MEDICAL SCHOOL
Manisha Brahmachary
Associate Director,
Sanofi USA
Manoj Kandpal
Director of Research Bioinformatics,
The Rockefeller University
Marina Bleck
Principal Scientist,
Boehringer Ingelheim Pharmaceuticals, Inc.
Matt Kanke
Senior Scientist,
Amgen
Mehdi Damaghi
Assistant Professor,
Stony Brook University
Mena Kamel
Computational Scientist,
Sanofi
Mike G Makrigiorgos
Director,
Dana-Farber Cancer Institute
Nikolai Slavov
Professor,
Northeastern University
Nir Ben Chetrit
Principal Investigator,
Weill Cornell Medicine
Noriko Satake
Professor,
UC Davis
Priyank Patel
Senior Scientist,
Boehringer Ingelheim RCV GmbH & Co KG
Rajib Schubert
Assistant Professor, KAIST,
KAIST
Rigel Chan
Assistant professor ,
UMass Chan Medical School
Ruslan Sadreyev
Director of Bioinformatics,
Massachusetts General Hospital
Ruslan Strogantsev
Staff Scientist,
OHSU
Sammy Ferri-Borgogno
Assistant Professor,
Anderson Cancer Center
Seungpyo Hong
Professor,
University of Wisconsin-Madison
Shoh Asano
Senior Principal Scientist,
Pfizer
Shuqiang Li
Lead Scientist, Translational Immunogenomic Laboratory ,
Dana-Farber Cancer Institute
Silvia Siso
Scientist-Pathologist,
AbbVie
Stephen T Wong
Chair & Professor,
Houston Methodist Hospital
Sydney Lavoie
Principle Scientist,
Pfizer
Theodore Perkins
Senior Scientist,
Ottawa Health Research Institute
Tien Phan-Everson
Scientist II,
Allen Institute for Immunology
William Stephenson
Principal Scientist, Technology,
Genentech
Winston Hide
Associate Professor,
Beth Israel Deaconess Medical Center / Harvard Medical School
Xiang Chen
Associate Member Computational Biology,
St. Jude Children's Research Hospital
Xiaofeng Jiang
Senior Scientist,
EMD Serono
Yan Tang
Assistant Professor,
Brigham & Women’s Hospital
Yasser Riazalhosseini
Associate Professor,
McGill University
Yesim Gokmen-Polar
Associate Professor,
Emory University School of Mediicne
Yu Tian
Director,
Abbvie
Yuhwa Lo
Professor,
University of California
Zhaleh Safikhani
Principal Scientist,
AbbVie
Zongmei Gao
Senior Scientist,
AbbVie
Exact Sciences Logo

"NextGen Omics US 2024 was a great networking opportunity, the meeting aspect of appointment setting was great. Everyone has been so helpful and responsive and ahead of our needs."


Regional Oncogenomic Liaison

Exact Sciences

ScipioBio

 

"The support from the Oxford Global team at NextGen Omics US 2024 was excellent - everyone went beyond to help us, it is rare to experience such support."


Chief Business Officer
Scipio Bio

b6fc1bbe-f2c7-48f4-ab7b-860f705182f9-2-5668375logo-logo-levitasbio-R-full-color-(1)

 

"Very professional and a high dedication to vendor needs and delivering on agreed upon packages. Christian is extremely attentive and customer driven, and this is also demonstrated by the Oxford Global team."

Senior Product Marketing Manager
Levitasbio

BD Logo-1

 

"NextGen Omics US was well organised, with highly relevant and engaged attendees."


Senior Sales Specialist, Single-Cell Multiomics
Business Development Manager – Northern Europe, Canopy Biosciences® – A Bruker Company

Allumiqs

 

"NextGen Omics US 2024 was a great, we got good value out of it and are considering coming back to another event!"


Digital Marketing Manager

Allumiqs

Interested in Sponsoring NextGen Omics & Spatial Biology US 2025?

Become a driving force in accelerating the next generation of multi-omics-based treatments. NextGen Omics & Spatial Biology US offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, & academic experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, & collaborate with the community shaping the future of genomic medicine today.

Interested in Sponsoring NextGen Biomed?

Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.

Interested in Sponsoring NextGen Omics, Spatial & Data US 2026?

Become a driving force in accelerating the next generation of multi-omics-based treatments. NextGen Omics, Spatial & Data US offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, & academic experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, & collaborate with the community shaping the future of genomic medicine today.

Plan Your Visit

Sheraton Boston Hotel
39 Dalton Street, Boston, Massachusetts, USA, 02199

Directions

 

By Air
The Sheraton Boston Hotel is conveniently located near Boston Logan International Airport (BOS), just a 15–20-minute drive away.

  • By Public Transport: Take the SL1 (Silver Line) bus from the airport to South Station (free). From South Station, transfer to the MBTA Green Line (E Branch) towards Heath Street and alight at Prudential Station, a short walk from the hotel.
  • By Shuttle Service: Airport shuttles are available; book in advance for door-to-door service.

For more information on airport services, visit the Logan International Airport website.

 

By Tram
Take the Green Line (B, C, or D) to Hynes Convention Center Station. The hotel is a short 3-minute walk from the station. Exit the station, head west along Massachusetts Avenue, and you’ll see the hotel on Dalton Street.

 

By Bus
Several MBTA bus routes stop near the hotel. Use routes 1, 39, or 55 to reach the Hynes Convention Center area. From the bus stop, it’s a quick walk to the hotel on Dalton Street.


Plan your trip using the MBTA website or app for real-time schedules.

 

By Rail
Getting to the Sheraton Boston Hotel by rail is simple and convenient. The hotel is located near major train stations in Boston, making it easily accessible. If arriving via Amtrak, disembark at Back Bay Station, which is just a 10-minute walk from the hotel. Alternatively, you can take a short taxi or rideshare trip. For those travelling on the MBTA Commuter Rail, Back Bay Station also serves as a central hub.


If you arrive at South Station, Boston’s main rail terminal, you can transfer to the Orange Line subway and travel to Back Bay Station in approximately 5 minutes. From there, follow the walking route to the Sheraton Boston Hotel. For added convenience, the hotel is also connected to the Prudential Center, which has easy access points if you’re navigating through the city’s pedestrian pathways.

Be sure to check train schedules and plan your journey ahead. For detailed directions, refer to the MBTA or Amtrak websites.

 

By Car

The Sheraton Boston Hotel is conveniently located in the heart of Boston, at 39 Dalton Street. For the easiest route, we recommend using GPS for real-time directions, ensuring an efficient journey.

When travelling by car, consider that the surrounding area can experience heavy traffic, especially during peak hours. It’s advisable to allow extra time for travel to account for potential delays.


Tip
: Due to Boston's busy streets and ongoing construction, we suggest checking traffic updates and planning your route in advance.

 

Parking

Sheraton Boston offers valet parking at a daily rate of $70. More details can be found on their website here.

Ensure to check for any changes or availability via the hotel's website.

Oxford Global does not have any contracted rooms at the Sheraton Boston Hotel. However, the hotel should have rooms available at their standard rates. We encourage you to contact the hotel directly for availability and pricing.

 

Below is a list of nearby hotels that you may find convenient for your stay:

Please note: While we have provided this list for your convenience, we strongly recommend conducting independent research to ensure that the accommodation suits your specific needs and preferences. Rates and availability may vary, so we suggest booking early to secure your stay.

We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.

As we continue to move forward with hosting our events in-person in 2025, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.

Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.

Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.

If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of NextGen Omics & Spatial Biology US 2025 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.

Interested in NextGen Omics, Spatial & Data US 2026?